APG-115 (alrizomadlin)
NCT03781986
University of Michigan · Phase 1/2 · Active, not recruiting · Enrollment 41
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
APG-115 (alrizomadlin)
University of Michigan · Phase 1/2 · Active, not recruiting · Enrollment 41
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.